Details of the Drug
General Information of Drug (ID: DMXLE71)
Drug Name |
SYL-040012
|
||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synonyms | SYL-0012; Beta 2 adrenoceptor-targeting siRNA (ocular hypertension), Sylentis | ||||||||||||||||||||||
Indication |
|
||||||||||||||||||||||
Drug Type |
siRNA drug
|
||||||||||||||||||||||
Sequence |
>Subunit 1
CUGGAUCACAUGCACAAUGTT >Subunit 2 CAUUGUGCAUGUGAUCCAGTT |
||||||||||||||||||||||
Cross-matching ID | |||||||||||||||||||||||
Molecular Interaction Atlas of This Drug
Drug Therapeutic Target (DTT) |
|
||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Molecular Interaction Atlas (MIA) | |||||||||||||||||||||||||||
Molecular Expression Atlas of This Drug
The Studied Disease | Ocular hypertension | |||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ICD Disease Classification | 9C61.01 | |||||||||||||||||||||||
|
||||||||||||||||||||||||
Molecular Expression Atlas (MEA) | ||||||||||||||||||||||||